4D Molecular Therapeutics CEO David Kirn disposes of 12,415 shares worth $124,987

• 4D Molecular Therapeutics President, CEO, director David Kirn sold 12,415 common shares on Aug. 3, 2026.
• Shares sold at a weighted average price of $10.05.
• Kirn held 871,737 shares following the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 4D Molecular Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-333014), on August 04, 2026, and is solely responsible for the information contained therein.